SLU-PP-332 is not a peptide
Despite the legacy URL and online marketing category, SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptors, not an amino-acid peptide. It is a laboratory chemical probe with no FDA-approved product, indication, or human dose.
“Exercise mimetic” refers to mouse experiments
In mice, SLU-PP-332 increased oxidative muscle-fiber features and exercise endurance through ERRα-dependent signaling.[1] A later study in mouse models of obesity reported lower fat mass and improved metabolic measures.[2] These studies did not test people, and “exercise mimetic” does not mean the compound reproduces the cardiovascular, musculoskeletal, neurological, or mortality benefits of exercise.
Human safety and efficacy are unknown
There is no controlled human exposure program, clinical pharmacokinetic profile, adverse-reaction table, validated dose, pregnancy information, interaction assessment, or long-term carcinogenicity evidence. Online claims about fat loss, endurance, or a pill that replaces exercise go beyond the published evidence.
Regulatory status
SLU-PP-332 is an unapproved research compound in the United States. Teloryx does not publish a human dose, cycle, stack, or preparation protocol.